Re-challenge therapy with chemotherapy and panitumumab in metastatic colorectal cancer patients treated with an anti-EGFR therapy in 1st line treatment: a phase II multicentre study.
2022-06-30
عنوان الدراسة
Re-challenge therapy with chemotherapy and panitumumab in metastatic colorectal cancer patients treated with an anti-EGFR therapy in 1st line treatment: a phase II multicentre study.
داعم الدراسة
King Abdullah Medical City, Holy Capital
دواء الدراسة
PANITUMUMAB
رقم بروتوكول الدراسة
19-504
حالة الدراسة
Ongoing
موقع الدراسة
KAMC
مرحلة الدراسة
2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。